Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy - Wang,X.Z.; Beebe,J.R.; Pwiti,L.; Bielawska,A.; Smyth,M.J. (Cancer Res, 1999)